Stock Comparison
ABBV vs GILD
AbbVie Inc and Gilead Sciences Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$171.48B
P/E (TTM)
70.3
—
Forward P/E
17.7
15.8
Price/Sales
6.8
5.6
Price/Book
51.1
14.5
EV/EBITDA
25.8
104.8
Dividend Yield
2.03%
1.74%
Profitability
Net Margin
9.82%
30.99%
Operating Margin
29.77%
38.61%
Return on Equity
62.30%
-20.70%
Return on Assets
10.50%
14.10%
Growth (YoY)
Revenue Growth
10.20%
10.20%
Earnings Growth
290.40%
54.80%
Price & Risk
Beta
0.3
0.3
52-Week High
$263.65
$154.92
52-Week Low
$197.38
$109.22
Analyst Target
$274.36
$157.41
Compare ABBV and GILD your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.